Education
About Us
Working with TipRanks
Follow Us
Akums Drugs and Pharmaceuticals Limited (IN:AKUMS)
:AKUMS
Total Valuation
Akums Drugs and Pharmaceuticals Limited has a market cap or net worth of ₹66.62B. The enterprise value is ₹67.95B.
Market Cap₹66.62B
Enterprise Value₹67.95B
Share Statistics
Akums Drugs and Pharmaceuticals Limited has 157,393,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding157,393,980
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Akums Drugs and Pharmaceuticals Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee5.40M
Profits Per Employee458.14K
Employee Count7,536
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Akums Drugs and Pharmaceuticals Limited is 20.4. Akums Drugs and Pharmaceuticals Limited’s PEG ratio is 0.00.
PE Ratio20.4
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio0.00
Income Statement
In the last 12 months, Akums Drugs and Pharmaceuticals Limited had revenue of 40.71B and earned 3.38B in profits. Earnings per share was 22.60.
Revenue40.71B
Gross Profit16.05B
Operating Income3.11B
Pretax Income3.45B
Net Income3.38B
EBITDA5.29B
Earnings Per Share (EPS)22.60
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Akums Drugs and Pharmaceuticals Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.58
52-Week Price Change-27.71%
50-Day Moving Average441.86
200-Day Moving Average494.69
Relative Strength Index (RSI)43.66
Average Volume (3m)11.50K
Important Dates
Akums Drugs and Pharmaceuticals Limited upcoming earnings date is Feb 5, 2026, Before Open (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateFeb 5, 2026
Ex-Dividend Date―
Financial Position
Akums Drugs and Pharmaceuticals Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Akums Drugs and Pharmaceuticals Limited has paid 14.76M in taxes.
Income Tax14.76M
Effective Tax Rate―
Enterprise Valuation
Akums Drugs and Pharmaceuticals Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Akums Drugs and Pharmaceuticals Limited has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Akums Drugs and Pharmaceuticals Limited is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―